Drug recall
Apheresis Platelets, Platelet Additive Solution Added, Leukocytes Reduced
FDA recall event 87325 · Class II · American Red Cross Blood Services
Key facts
| Event ID | 87325 |
|---|---|
| Recall numbers | B-0293-2021 |
| Recalling firm | American Red Cross Blood Services |
| Product type | Biologics |
| Products | Apheresis Platelets, Platelet Additive Solution Added, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Leukoreduced, Apheresis Platelets, Platelet Additive Solution Added, collected in a manner that compromises the sterility of the collection system, were distributed. |
| Initiation date | Dec 27, 2020 |
| Report date | Mar 3, 2021 |
| Termination date | Feb 19, 2021 |
| City | Farmington |
| State | CT |
| Country | United States |
| FEI number | 1273014 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: